This page was created to update our clients on the most important DOT news related to the COVID-19 Health Emergency.
The CDL & Medical waiver has been extended to February 28, 2021! Click the link below to download the waiver.
CDL licenses that expired on or after March 1, 2020 have been extended to May 31, 2021.
Medicals that expired on or after December 1,2020 have been extended to May 31, 2021.
FMCSA has issued the following guidance on disruptions to Drug & Alcohol Testing.
1. Random Testing - If, due to disruptions caused by the COVID-19 national emergency, you are unable to perform random selections and tests sufficient to meet the random testing rate for a given testing period in order to achieve the required 50% rate for drug testing, and 10% for alcohol testing, you should make up the tests by the end of the year. You should document in writing the specific reasons why you were unable to conduct tests on drivers randomly selected, and any actions taken to locate an alternative collection site or other testing resources.
2. Pre-Employment Testing - If you are unable to conduct a pre-employment controlled substances test, in accordance with 49 CFR 382.301(a), you cannot allow a prospective employee to perform DOT safety sensitive functions until you receive a negative pre-employment test result, unless the exception in 49 CFR 382.301(b) applies.
3. Post-Accident Testing - You are required to test each driver for alcohol and controlled substances as soon as practicable following an accident as required by 49 CFR 382.303. However, if you are unable to administer an alcohol test within 8 hours following the accident, or a controlled substance test within 32 hours following the accident, due to disruptions caused by the COVID-19 national emergency, you must document in writing the specific reasons why the test could not be conducted, as currently required.
4. Reasonable Suspicion Testing - You should document in writing the specific reasons why the test could not be conducted as required; include any efforts you made to mitigate the effect of the disruption, such as trying to locate an alternative collection site. This documentation should be provided in addition to the documentation of the observations leading to a test, as required by 49 CFR 382.307(f)
5. Return-to-duty Testing - In accordance with 49 CFR 40.305(a), you must not allow the driver to perform any safety-sensitive functions, as defined in 49 CFR 382.107, until the RTD test is conducted and there is a negative result.
6. Follow-up Testing - If testing cannot be completed, you should document in writing the specific reasons why the testing could not be conducted as in accordance with the follow-up testing plan; you should include any efforts you made to mitigate the effect of the disruption, such as trying to locate an alternative collection site. You should conduct the test as soon as practicable.
Transportation Network Training, Inc.
41 Gauthier Dr
Essex Junction, VT 05452
Phone: (802) 879-9985
Fax: (802) 879-7740
BY APPOINTMENT ONLY!